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MEETING REVIEW
Quantitative stem cell biology: the threat and the glory
Steven M. Pollard*
ABSTRACT
Major technological innovations over the past decade have
transformed our ability to extract quantitative data from biological
systems at an unprecedented scale and resolution. These
quantitative methods and associated large datasets should lead to
an exciting new phase of discovery across many areas of biology.
However, there is a clear threat: will we drown in these rivers of data?
On 18th July 2016, stem cell biologists gathered in Cambridge for the
5th annual Cambridge Stem Cell Symposium to discuss ‘Quantitative
stem cell biology: from molecules to models’. This Meeting Review
provides a summary of the data presented by each speaker, with a
focus on quantitative techniques and the new biological insights that
are emerging.
KEY WORDS: Bioinformatics, Computational biology, Epigenetics,
Genome editing, Stem cells, Transcription
Introduction
Quantitative approaches have been boosted across many areas of
biology by the relentless improvements in sequencing, imaging,
computational methods and computational power. Stem cell biology
sits at the intersection of classical developmental biology and cell
biology, and a central question is how gene activity shifts in space and
time to direct specific cell fates. The 5th annual Cambridge Stem Cell
Symposium ‘Quantitative stem cell biology: from molecules to
models’ brought together researchers from around the world to
discuss their use of quantitative techniques to address this question. A
key theme for the meeting was the varied uses of next-generation
sequencing technologies to monitor gene transcription, epigenetics
and three-dimensional (3D) chromosome topology. These advances
have enabled us to begin to unearth the decision-making mechanisms
that govern specification and commitment to distinct cell fates. Other
interesting quantitative approaches, such as those relating to the
physical biology of stem cells, have been covered in previous
meetings in this series (Lowell, 2013).
Azim Surani (Gurdon Institute, University of Cambridge, UK),
who co-organised the meeting with Paul Bertone and Elisa Laurenti
(University of Cambridge), began by emphasising the power of new
quantitative methods and analytic tools. But therewas a clear caveat:
how do we best make sense of all this data? The meeting offered the
chance to hear just how far we have comewith regard to quantitative
data analysis, with some wonderful examples from pioneers in this
area. In this Meeting review, I outline the major ideas and topics that
emerged, focusing on the key processes that influence stem cell fate:
transcription, mitosis, epigenetics and fate specification.
Transcription and pluripotency
The paradigm experimental models for studying mammalian stem
cells were on full display throughout the meeting: pluripotent stem
cells and reprogramming, neural stem cells, haematopoietic stem
cells and epidermal stem cells all featured throughout the talks. Rick
Young (Whitehead Institute, USA) provided a superb overview of
mammalian transcriptional regulation based on work carried out
primarily on pluripotent stem cells. His group has been one of the
pioneers in establishing and exploiting techniques that enable
genome-wide analysis of transcription. In his plenary talk, Young
discussed the importance of genome organisation: the arrangement
of DNA in 3D space, and how this influences gene expression.
Mapping the topological organisation of chromosomes has been
one of the areas of research that has been boosted by next-generation
sequencing. Interacting sites are captured in their 3D conformation
and ligated before being mapped by deep sequencing. This
approach has revealed topologically associating domains (TADs)
as a fundamental structural unit of genome organisation (Gorkin
et al., 2014). Boundaries between TADs are largely shared between
different cell types, ruling out the idea that reconfiguration of
these boundaries could be regulating lineage commitment and
differentiation. However, Young presented evidence that within
each TAD the situation is more dynamic because of the presence of
‘insulated neighbourhoods’. These insulated neighbourhoods do
vary between cell types and are defined by highly conserved nuclear
protein CCCTC-binding factor (CTCF) sites that are secured by
cohesin (Dowen et al., 2014). Insulated neighbourhoods offer a
solution to the long-standing conundrum of how enhancers identify
the right target: they simply have no choice where to loop. How
these insulated neighbourhoods are set up in the first instance and
how they can be dynamically controlled are important questions for
the field.
Analysis of pluripotent stem cells by Young and co-workers
has revealed that there are approximately 10,000 insulated
neighbourhoods across the genome, which are, on average 200 kb
in size, but can range from 4 kb to 3 Mb, and contain one or two
genes. This new knowledge has immediate and broad significance
for human disease studies. For example, many of the disease-
associated single nucleotide polymorphisms (SNPs) identified in
human genome-wide association studies are located within
enhancers. This is also the case for many somatic cancer mutations.
The pluripotency transcriptional network was a topic also
covered in computational modelling talks from both Sara-Jane
Dunn (Microsoft Research, Cambridge, UK) and Ingo Roeder
(IMB, Dresden, Germany). Roeder discussed how he has been
using computational strategies to model the emergence of
transcription factor heterogeneity from the core pluripotency gene
regulatory network (GRN) (Herberg and Roeder, 2015). He
provided a clear example of how modelling generates useful and
testable hypotheses – in this instance whether the core pluripotency
GRN would result in oscillatory behaviour or whether it is more
likely to generate uncoordinated fluctuations. Comparing
experimental observations with his modelling results suggest theReceived 20 September 2016; Accepted 3 October 2016
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latter. A major problem, however, is that even with the most
powerful computers it would be impractical to compute and explore
all possible network topologies. So how do we reduce the
complexity? One solution is to filter out candidate GRNs that do
not fit with known experimental data. This cannot be performed
manually, and so new computational approaches are needed. Dunn
has been tackling this together with Austin Smith (Dunn et al.,
2014). She described a new tool – the reasoning engine for
interaction networks (RE:IN) – which was devised to sidestep the
need for computationally intensive simulations (Yordanov et al.,
2016). Taking a mathematical approach, experimental observations
are encoded as constraints, allowing the user to synthesise only
those networks that are consistent with experiments. This is a
computationally efficient way to quickly filter models that do not
make sense. The power of this strategy was demonstrated in the
establishment of a more accurate and extended core pluripotency
GRN, and the identification of new regulatory interactions that
would otherwise have been impossible to deduce. Importantly,
these have been functionally validated to provide confidence in the
approach (Dunn et al., 2014). Her ongoing efforts are now focussed
on how this network is established during reprogramming.
Diagrams that illustrate core GRNs often imply a very static and
stable cell state. But this is inappropriate, as cells often display
significant cell-cell variability and fluctuations in gene expression.
Such heterogeneity may underpin the diverse differentiation paths
available to otherwise phenotypically equivalent cells. Naomi
Moris (Pina and Martinez-Arias laboratories, University of
Cambridge) discussed her efforts to explore the possible causes of
cellular heterogeneity and presented results indicating that the
chromatin remodeller Kat2a – the mammalian orthologue of yeast
Gcn5 – could be involved. In yeast, Gcn5 has been identified as a
candidate regulator of transcriptional noise. Intriguingly, Moris has
found evidence that inhibition of Kat2a in mouse embryonic stem
cells enhances Nanog transcriptional heterogeneity, destabilising
the pluripotent state and promoting differentiation.
GRNs undergo dynamic change as cells pass through the cell
cycle. Transcription ceases on mitotic chromosomes and a
longstanding idea has been that this mitotic interlude in
transcription provides a window of opportunity for new GRNs to
emerge. At the same time, however, self-renewal requires
persistence of the parental GRN. So how is the same
transcriptional state propagated to the daughter cells? An
attractive idea, which first emerged many years ago, is the
concept of mitotic bookmarking (John and Workman, 1998). This
hypothesis proposes that a subset of the critical lineage determining
transcription factors remain bound to the mitotic chromosomes,
thereby enabling rapid reactivation of their targets once mitosis is
complete. David Suter [École polytechnique fédérale de Lausanne
(EPFL), Switzerland] discussed his group’s efforts to determine
whether any of the members of the core pluripotency circuit might
act as mitotic bookmarkers. Immunocytochemistry has been
problematic for addressing this question, mainly because of
fixation artefacts. Suter presented an impressive systematic
assessment of fluorescent fusion variants for each of the factors in
the core network defined by Dunn and Smith (Dunn et al., 2014).
Using live cell imaging, he found that many of the core pluripotency
transcription factors do indeed remain localised to the condensed
chromosomes, consistent with their putative role as mitotic
bookmarking transcription factors. In ongoing studies, Suter is
exploring exactly where the transcription factors are bound, as well
as the tricky task of determining the functional consequences of
reducing bookmarking in mitotic pluripotent stem cells.
During direct reprogramming to pluripotency, the pluripotency
GRN must be established de novo. Noa Novershtern (Hanna Lab,
Weizmann Institute of Science, Israel) has been gaining mechanistic
insights into this process and discussed how a more efficient
reprogramming system – using cells mutant for Gatad2a and Mbd3,
which are both components of the NuRD complex – allows a survey
of transcriptional and chromatin changes without the need for
sorting or selection. The integrative analysis of these data uncovered
two distinct programs of gene expression changes during
reprogramming. In one, a cohort of chromatin regulatory genes
predominates, which is enriched for cell fate determinants. The
second program contains more cell maintenance-associated genes
that have a consistent active epigenetic configuration and includes
many Myc targets. This rich dataset will be an invaluable tool in the
effort to dissect the order of events during reprogramming and the
many layers of regulation therein.
Epigenetics
DNA methylation is the best understood example of epigenetic
control. It has long been considered to be critical for developmental
decision-making and stabilisation of differentiated phenotypes
(Smith and Meissner, 2013). Several talks covered this topic,
including a plenary talk from Alex Meissner (Harvard Medical
School, USA). Meissner first presented an overview of the
distribution and dynamics of DNA methylation in a normal
developmental context with specific examples during the
differentiation of human embryonic stem cells. He then described
his lab’s efforts to more closely inspect the mitotic inheritance of
DNA methylation using a genomic approach and presented his
hypothesis on the practical and biological relevance of these
findings. These results were further integrated with preliminary
results on how the pioneer transcription factor FoxA2 engages with
its targets and whether the observed changes in DNA methylation
are the result of active or passive mechanisms.
The Fox transcription factor family was also discussed in another
context by Steve Pollard (University of Edinburgh, UK). Cancer
stem cells derived from glioblastoma – a type of brain tumour –
frequently express high levels of FOX and SOX factors. Using
ATAC-Seq, a tractable and powerful method to define chromatin
accessibility genome-wide, Pollard presented evidence that FOX
and SOX factors are responsible for limiting terminal differentiation
(Caren et al., 2015). Furthermore, he was able to show that these
factors control many core cell cycle and epigenetic regulators. In
this way, cancer cells can be seen to hijack and subvert the
molecular apparatus used by stem and progenitor cells to fuel
unconstrained self-renewal.
Dynamic changes in epigenetic memory are essential for cells to
undergo dramatic changes in cell fate, whether during early
development, in the germ line or in direct reprogramming
experiments. Wolf Reik (Babraham Institute, UK) discussed his
recent data on how demethylation occurs during transition from the
primed embryonic stem cell state to the naïve state, which can be
imposed by culturing the cells under specific conditions. Despite
their pivotal role in demethylation, Tet proteins were found to be
dispensable (von Meyenn et al., 2016). Instead, demethylation
appeared to involve downregulation of Uhrf, which is the protein
responsible for recruiting Dnmt1 to the replication fork, thus
suggesting a failure of the DNA methylation maintenance
apparatus. Reik also discussed the role of DNA methylation in
contributing to the generation of cellular heterogeneity during cell
fate decision making in the early embryo. Underlying the
heterogeneity might be the competing influences of TET and
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DNMT3 coexpression, a strategy that Reik hypothesised could
create the heterogeneous patterns of methylation needed to seed
diverse cell fate options. He entranced us with the oscillating dance
of the dynamic methylation model he has developed with Ben
Simons. Moving forward, it will be necessary to track these changes
in live cells.
A battle between Tet and Dnmt3a has also been identified in
haematopoietic stem cells, and was discussed by Margaret Goodell
(Baylor College of Medicine, Houston, TX, USA). Haematopoietic
stem cells lacking Dnmt3a fail to differentiate efficiently, and recent
studies have found recurrent mutations in this gene as an early event
in various leukaemias. Goodell discussed how her laboratory has
identified large blocks of low DNA methylation called ‘canyons’,
which at >3.5 kb are much broader than CpG islands. There are
around 1000 of these DNAmethylation canyons and they are highly
enriched in developmental regulatory transcription factor binding
motifs. In Dnmt3a mutant haematopoietic stem cells, the
methylation boundaries at these canyons, which are enriched for
hydroxyl methylation, become eroded. By extension, then, the
maintenance methylase Dnmt1 is not sufficient to protect them
(Jeong et al., 2014). The boundaries appear to be restored when Tet2
is mutated, which suggests a model in which TET and DNMT3
compete at the edges of these canyons. It will be interesting to define
how these canyons relate to super-enhancers, TADs and insulated
neighbourhoods as described by Rick Young.
Discussions on Dnmt3 were continued by Salvador Aznar-
Benitah (IRB, Barcelona, Spain), who presented work exploring the
differentiation of adult stem cells in the absence of DNA
methylation – this time in the skin. Aznar-Benitah showed how
conditional knockout of Dnmt3a results in exacerbated ageing and
increased tumour initiation and he discussed some of the underlying
molecular mechanisms that contribute to the phenotype. He
explained how Dnmt3a and Dnmt3b activate super-enhancers that
regulate the expression of genes associated with stem cell self-
renewal and differentiation (Rinaldi et al., 2016). Interestingly,
Dnmt3a-mediated activation of super-enhancers requires their
subsequent hydroxymethylation by Tet2, supporting a synergistic
role of both proteins in gene regulation.
Fate specification
While the various ‘Seq’ and ’omics approaches have proved their
value, it is also clear that they have limitations, as they can only
provide snapshots and are often population-based averages. Direct
visual inspection of cell behaviours is essential to appreciate the
dynamics and kinetics of molecular and cellular changes. Timm
Schroeder (ETH, Zurich, Switzerland) presented his ongoing efforts
to continuously monitor gene activity in single cells. One of the key
challenges with this approach is the associated huge imaging
datasets that are collected and required to monitor fate and
differentiation. This is a problem we are all facing: the ease of
data collection is outstripping the ease of data analysis and new tools
are needed to make sense of it all. To this end, Schroeder has
assembled an impressive team of engineers, physicists, statisticians
and computer scientists to work together, and his presentation was a
demonstration of what can be achieved when such collaborations are
formed. Schroeder described how his team has tracked the lineage
choices of blood progenitors in vitro over the course of 2 weeks.
Focusing on the proposed bi-stable switch of PU.1 and GATA, he
measured the amount of protein every 30 min across many
thousands of cells over time. These data immediately revealed
that it is not a battle between these two factors that determines cell
fate; instead they serve to reinforce decisions that have already been
made (Hoppe et al., 2016). Indeed, the decisions appear to have
been made much earlier than anticipated – occurring five or more
cell divisions before fate commitment occurs. The molecular
explanation for this remains unclear.
While Schroeder presented the power of in vitro culture for
tracking cell fate over many days and weeks, it remains problematic
in intact organisms and tissue explants. However, technologies
enabling live cell imaging in vivo with cellular resolution have
emerged. A study using intravital imaging was presented by Saskia
Ellenbroek (van Rheenen lab, Hubrecht Institute, The Netherlands),
who has been using this approach to analyse intestinal stem cell
dynamics. Using live cell tracking in Lgr5 confetti mice, it appears
that a cell’s position within the intestinal crypt has an influence on
fate (Ritsma et al., 2014). Now, using similar technology, she is
exploring cancer cell differentiation and plasticity in breast cancer
models.
Multilayer ’omics analysis of haematopoietic stem cells and
their more lineage-restricted progenitors was presented by Nina
Cabezas-Wallscheid (Andreas Trumpp laboratory, DKFZ,
Heidelberg). Multipotent progenitors are the immediate progeny of
haematopoietic stem cells, but the regulatory factors that maintain and
distinguish these two populations remains unclear. In previous work,
Cabezas-Wallscheid has shown how extensive molecular profiling –
incorporating proteome, transcriptome andmethylome analyses – can
identify key regulatory elements in haematopoietic stem cells, which
can then be linked to their functional potential in vivo (Cabezas-
Wallscheid et al., 2014). In her talk, Cabezas-Wallscheid presented
data derived from bulk and single-cell RNA-Seq analysis comparing
dormant and active haematopoietic stem cells. These data
demonstrated a clear role for Myc in upregulating biosynthetic
processes to prime stem cells towards re-engagement of the cell cycle.
Interestingly, she showed how this process follows a continuum rather
than an on/off switch – something that has become increasingly clear
across many tissue stem cells. In functional experiments, Cabezas-
Wallscheid also identified retinoic acid/vitamin A as an important
regulator of haematopoietic stem cell dormancy.
Haematopoietic stem cells were also the focus of a talk from Sergei
Doulatov (George Daley laboratory, Harvard Medical School, USA),
who provided an excellent example of how useful it can be to generate
haematopoietic stem cells from human induced pluripotent stem cells
(iPSCs). Doulatov showed how the in vitro-generated haematopoietic
stem cells could be exploited for disease modelling and drug
discovery, with a focus on patients with Diamond–Blackfan anaemia.
Gerald de Haan (University Medical Center Groningen, The
Netherlands) continued on the haematopoietic stem cell theme,
discussing how his group is exploring the relationship between
ageing and haematopoietic stem cell function. He has used barcoding
to track haematopoietic stem cell clones and then measured clonal
output in those derived from either young or old mice that are co-
transplanted (Verovskaya et al., 2013). Interestingly, no loss of old
haematopoietic stem cells was observed, suggesting that their
decreased output was due to cell intrinsic deficits compromising
their function.
Joaquina Delas (Hannon lab, Cancer Research UK Cambridge
Research Institute) was one of the few talks that covered the role of
long noncoding RNAs (lncRNAs) in the haematopoietic system.
She identified the set of lncRNAs expressed in mouse – both in the
normal and disease state – using de novo transcriptome assembly.
These data formed the basis of a specific functional in vivo
assessment of the role of these lncRNAs in acute myeloid leukaemia
(AML) progression. Among the hits identified were several
lncRNAs required to maintain the expression of signature
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leukaemic stem cell genes. Upon depletion of these lncRNAs, cells
upregulated myeloid differentiation markers. These lncRNAs seem
to operate through the Myc transcription factor, as Myc levels were
reduced upon lncRNA knockdown, and enforced expression ofMyc
rescued the phenotype. The future focus of this work will be to
resolve mechanistically how lncRNAs can influenceMyc, as well as
their role in normal fate choice.
Concluding remarks: Seq and ye shall find
The meeting ended with a plenary talk from Alexander Van
Oudenaarden (Hubrecht Institute, The Netherlands). Single-cell
analysis has opened the door to a more refined understanding of cell
states and transitions, and Van Oudenaarden provided some
impressive examples of the power of these approaches to define
the repertoire of cell types and states. He has also been exploiting the
CRISPR/Cas system, repurposing it to knock-in barcodes that
enable the parallel tracking of lineages in whole organisms. This a
powerful approach that has also been successfully used by others
(McKenna et al., 2016). Van Oudenaarden made an important point
concerning the recent rapid convergence of many different single
cell assays and approaches: the time has come where these distinct
methods can be integrated to gain a more coherent view of stem cell
states and behaviours. Stem cell biologists working with ‘classic’
single-cell analyses, such as immunocytochemistry, flow cytometry
and live-cell imaging now have the opportunity to link these
methods with the powerful single-cell ’omics approaches. As the
barriers to these technologies are reduced and analytical tools
become quicker and more reliable, we will undoubtedly witness a
new phase of integrative quantitative analysis in which a coherent
picture of cell states can be readily obtained.
One obvious point to emerge from the meeting was the rapid
adoption of CRISPR/Cas across many areas. A number of elegant
and clever approaches demonstrated how this new-found ability to
edit the genome can be used for lineage tracing, library screens and
epigenome editing. There were also several examples of how
CRISPR/Cas genome editing enables functional annotation of gene
regulatory elements; an impressive new toolkit for the dissection of
regulatory circuits within the human genome. Another theme to
emerge was the requirement for better tools to monitor the dynamics
of gene regulation in live cells, ideally at single-cell resolution. It
was also striking how many speakers are making insights that
directly inform our understanding of human cancer: the
longstanding promise of developmental and stem cell biology to
help tackle human cancer perhaps finally coming to fruition.
After dinner at Magdalene College, meeting attendees strode into
town for some well-earned refreshment, passing by Portugal Place,
the former home of Francis Crick. It is now over half a century since
he and Watson uncovered the structure of DNA – the secret of life –
and over 15 years since the human genome was deciphered. Crick
would surely be astonished by our new-found ability to routinely
sequence and edit human genomes, and to globally survey gene
expression patterns. These new rivers of data do not necessarily
mean we will drown; but more than ever we need collaborative
approaches to take advantage of the opportunities they offer.
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